China | Implementation measures for the Fair Competition Review Regulations released
China’s State Administration for Market Regulation released the Implementation Measures for the Fair Competition Review Regulations (“the Measures”) on 18 March 2025. The Measures aim to strengthen the enforcement...
China’s State Administration for Market Regulation released the Implementation Measures for the Fair Competition Review Regulations (“the Measures”) on...
Read More
China | Recent updates on post-filing data for patent applications
In China's patent examination practice, the technical effects demonstrated by experimental data are a crucial factor for patent applications, especially for biotech and chemical inventions. In order to address objections...
In China's patent examination practice, the technical effects demonstrated by experimental data are a crucial factor for patent applications,...
Read More
China | Patent examination shift for siRNA drugs in China
With the rapid expansion of siRNA research and application worldwide, the number of patent applications has also surged. An analysis of prosecution history of various siRNA patent applications in...
With the rapid expansion of siRNA research and application worldwide, the number of patent applications has also surged. An...
Read More
China | Increased evidence required for Non-Use Trademark Cancellations
The China National Intellectual Property Administration (CNIPA) has issued rectification notices to certain trademark agencies and law firms concerning non-use cancellation applications. The move removes the ability to file...
The China National Intellectual Property Administration (CNIPA) has issued rectification notices to certain trademark agencies and law firms concerning...
Read More
China | Post-filing data in addressing non-support issues
Since 2021, it has become common practice in China to use post-filing data to address issues related to inventiveness and sufficient disclosure. However, there is a general perception that...
Since 2021, it has become common practice in China to use post-filing data to address issues related to inventiveness...
Read More
China | Intellectual property enforcement trends positive for foreign entities
Over the last ten years, China has made considerable changes to its intellectual property enforcement mechanisms, including specialised IP courts in key cities such as Beijing, Shanghai and Guangzhou....
Over the last ten years, China has made considerable changes to its intellectual property enforcement mechanisms, including specialised IP...
Read More
China | Guidelines for AI-related invention applications (trial) released
On December 31, 2024, the China National Intellectual Property Administration (CNIPA) released the Guidelines for AI-related Invention Applications (Test Implementation), addressing several legal aspects, including inventor qualification/identification, for Artificial...
On December 31, 2024, the China National Intellectual Property Administration (CNIPA) released the Guidelines for AI-related Invention Applications (Test...
Read More
China | Resolving a 30-year legacy: Key lessons from the ‘DELIXI’ case on Intellectual property and unfair competition
In September 2024, the Shanghai Intellectual Property Court (Court of Second Instance) delivered a final judgment in the long-standing trademark infringement and unfair competition case between DELIXI Group Corporation...
In September 2024, the Shanghai Intellectual Property Court (Court of Second Instance) delivered a final judgment in the long-standing...
Read More
China and New Zealand – Patent Prosecution Highway (PPH)
On 1 November 2024, the China National Intellectual Property Administration (CNIPA) announced the launch of the Patent Prosecution Highway (PPH) with the Intellectual Property Office of New Zealand (IPONZ)....
On 1 November 2024, the China National Intellectual Property Administration (CNIPA) announced the launch of the Patent Prosecution Highway...
Read More
Pharmaceutical Patent disputes in China | The nuances of “offer to sell”
The application of Bolar exceptions and the definition of "offer to sell" have long been contentious issues in the pharmaceutical industry in China. Article 11 of the Chinese Patent Law...
The application of Bolar exceptions and the definition of "offer to sell" have long been contentious issues in the pharmaceutical...
Read More
Landmark IP Decision by China Supreme Court
The Supreme Court of the P.R. China recently announced the decision of an appeal case involving a dispute over patents and technology secrets related to new energy vehicle chassis...
The Supreme Court of the P.R. China recently announced the decision of an appeal case involving a dispute over...
Read More

Contact our Expert Team

Contact Us
Contact Us